IPA's Subsidiary, BioStrand, Provides an Update on LENSai Se

25.10.2023 - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, announces that its subsidiary, BioStrand, has commercially launched its state-of-the-art Retrieval ... Seite 1

Related Keywords

, Knowledge Graphs , Knowledge Graph , Symbolic Methodology , Augmented Generation , Retrieval Augmented Generation , Large Language Model , Immunoprecise Antibodies Chart , Mmunoprecise Antibodies Kurs , Mmunoprecise Antibodies Aktie ,